Impact of the addition of carboplatin to anthracycline-taxane-based neoadjuvant chemotherapy on survival in BRCA1/2-mutated triple-negative breast cancer.,Int J Cancer,148(4):941-949

Prevalence and characterization of ATM germline mutations in Chinese BRCA1/2-negative breast cancer patients.,Breast Cancer Res Treat,174 (3):639-647.

RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients.,Int J Cancer,143(8):1935-1942

Prevalence of BRCA1/2 large genomic rearrangements in Chinese women with sporadic triple-negative or familial breast cancer.,Clin Genet,94(1):165-169

Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer.,Breast Cancer Res Treat,158（3）:455–462

肿瘤易感62基因及其应用, 发明专利, 第3完成人 , 国家知识产权局, 中国, 2019.12

中国人群特有的BRCA1/2基因内含子突变对BRCA1/2功能的影响及与乳腺癌发病的相关性分析, 课题负责人 , 2014.1.1～2016.12.31, 国家自然科学基金

BRCA1/2大片段重排在中国三阴性乳腺癌中的作用及功能研究, 课题负责人 , 2018.1.1～2020.12.31, 北京市自然科学基金

BRCA1/2突变三阴性乳腺癌对蒽环类药物耐药机制研究, 课题负责人 , 2018.1.1～2021.12.31, 国家自然科学基金

BRCA1/2大片段重排突变与乳腺癌发病风险及新辅助化疗疗效相关性研究, 课题负责人 , 2017.1.1～2018.12.31, 北京市医院管理局青苗计划